You are using an unsupported browser. Please use the latest version of Chrome, Firefox, Safari or Edge.
The one hundred honoree: Susan Eid

Donor Story

The one hundred honoree: Susan Eid

Mass General Giving

“Susan was all about giving.” Those words, spoken by Cindy Eid about her sister, capture her best. While Susan was waging her personal battle against metastatic breast cancer, she also fought back by donating to Mass General’s breast cancer research.

Under the care of Beverly Moy, MD, clinical director of the Breast Oncology Program at the Mass General Cancer Center, and Dejan Juric, MD, medical oncologist in the Henri and Belinda Termeer Center for Targeted Therapies at the Mass General Cancer Center, Susan learned her breast cancer had a unique genetic mutation that could be targeted through clinical trial therapies. Susan participated in a clinical trial to treat her own cancer and began supporting research for targeted therapies, as well as research to improve access to clinical trials for underserved patients.

“I’ll never forget her reaction one time after I thanked her for one of her donations,” says Dr. Moy. “She began to cry and waved her hands, gesturing me to stop thanking her. She didn’t want praise or gratitude.”

Susan’s humility extended to her professional accomplishments as well. Few at Mass General knew Susan was the highly respected senior vice president for government and regulatory affairs at DIRECTV.

True to who she was, Susan continues to give even after her death. Before her passing in November 2014, Susan and her sister Cindy realized that Susan’s body contained precious cancer cells that could be used for scientific research to learn more about resistance to targeted therapies. After she passed away, Susan provided the ultimate gift: cancer cells and tissues were taken from her body for scientific studies in hopes that her doctors would learn how to better treat women with breast cancer.

“Susan gave all that she had so that other women diagnosed with this dreadful disease may live,” says Dr. Moy.